These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32589959)

  • 21. Identifying Signalling Pathways Regulated by GPRC5B in β-Cells by CRISPR-Cas9-Mediated Genome Editing.
    Atanes P; Ruz-Maldonado I; Hawkes R; Liu B; Persaud SJ; Amisten S
    Cell Physiol Biochem; 2018; 45(2):656-666. PubMed ID: 29408822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful CRISPR/Cas9 mediated homologous recombination in a chicken cell line.
    Antonova E; Glazova O; Gaponova A; Eremyan A; Zvereva S; Grebenkina N; Volkova N; Volchkov P
    F1000Res; 2018; 7():238. PubMed ID: 29946437
    [No Abstract]   [Full Text] [Related]  

  • 23. Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.
    Bubeck F; Hoffmann MD; Harteveld Z; Aschenbrenner S; Bietz A; Waldhauer MC; Börner K; Fakhiri J; Schmelas C; Dietz L; Grimm D; Correia BE; Eils R; Niopek D
    Nat Methods; 2018 Nov; 15(11):924-927. PubMed ID: 30377362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Exosome-mediated CRISPR/Cas9 system targets to cut the intercellular transmission function of hepatitis B virus genome].
    Wang J; Chen R; Lu FM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):610-614. PubMed ID: 31594078
    [No Abstract]   [Full Text] [Related]  

  • 25. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA.
    Zhu W; Lei R; Le Duff Y; Li J; Guo F; Wainberg MA; Liang C
    Retrovirology; 2015 Feb; 12():22. PubMed ID: 25808449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR/Cas9 Genome Editing in Embryonic Stem Cells.
    Andrey G; Spielmann M
    Methods Mol Biol; 2017; 1468():221-34. PubMed ID: 27662879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9-Mediated Knockin of Retinoschisin 1 Gene-A Potential Nonviral Therapeutic Solution for X-Linked Juvenile Retinoschisis.
    Chou SJ; Yang P; Ban Q; Yang YP; Wang ML; Chien CS; Chen SJ; Sun N; Zhu Y; Liu H; Hui W; Lin TC; Wang F; Zhang RY; Nguyen VQ; Liu W; Chen M; Jonas SJ; Weiss PS; Tseng HR; Chiou SH
    Adv Sci (Weinh); 2020 May; 7(10):1903432. PubMed ID: 32440478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDAd5/35
    Li C; Psatha N; Gil S; Wang H; Papayannopoulou T; Lieber A
    Mol Ther Methods Clin Dev; 2018 Jun; 9():390-401. PubMed ID: 30038942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome Editing in Cotton with the CRISPR/Cas9 System.
    Gao W; Long L; Tian X; Xu F; Liu J; Singh PK; Botella JR; Song C
    Front Plant Sci; 2017; 8():1364. PubMed ID: 28824692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two CRISPR/Cas9-mediated methods for targeting complex insertions, deletions, or replacements in mouse.
    Pineault KM; Novoa A; Lozovska A; Wellik DM; Mallo M
    MethodsX; 2019; 6():2088-2100. PubMed ID: 31667107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunocytochemistry and fluorescence imaging efficiently identify individual neurons with CRISPR/Cas9-mediated gene disruption in primary cortical cultures.
    Tsunematsu H; Uyeda A; Yamamoto N; Sugo N
    BMC Neurosci; 2017 Aug; 18(1):55. PubMed ID: 28764650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system.
    Bevacqua RJ; Fernandez-Martín R; Savy V; Canel NG; Gismondi MI; Kues WA; Carlson DF; Fahrenkrug SC; Niemann H; Taboga OA; Ferraris S; Salamone DF
    Theriogenology; 2016 Nov; 86(8):1886-1896.e1. PubMed ID: 27566851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A carrier-free multiplexed gene editing system applicable for suspension cells.
    Ju A; Lee SW; Lee YE; Han KC; Kim JC; Shin SC; Park HJ; EunKyeong Kim E; Hong S; Jang M
    Biomaterials; 2019 Oct; 217():119298. PubMed ID: 31280073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabrication and characterization of PLGA nanoparticles encapsulating large CRISPR-Cas9 plasmid.
    Jo A; Ringel-Scaia VM; McDaniel DK; Thomas CA; Zhang R; Riffle JS; Allen IC; Davis RM
    J Nanobiotechnology; 2020 Jan; 18(1):16. PubMed ID: 31959180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances in Genome Editing Using CRISPR/Cas9.
    Ding Y; Li H; Chen LL; Xie K
    Front Plant Sci; 2016; 7():703. PubMed ID: 27252719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous single-cell profiling of lineages and cell types in the vertebrate brain.
    Raj B; Wagner DE; McKenna A; Pandey S; Klein AM; Shendure J; Gagnon JA; Schier AF
    Nat Biotechnol; 2018 Jun; 36(5):442-450. PubMed ID: 29608178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatial and temporal control of gene manipulation in Drosophila via drug-activated Cas9 nucleases.
    Huynh N; Wang S; King-Jones K
    Insect Biochem Mol Biol; 2020 May; 120():103336. PubMed ID: 32105778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A CRISPR/Cas9-based system for reprogramming cell lineage specification.
    Chakraborty S; Ji H; Kabadi AM; Gersbach CA; Christoforou N; Leong KW
    Stem Cell Reports; 2014 Dec; 3(6):940-7. PubMed ID: 25448066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
    Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
    Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chromosomal large fragment deletion induced by CRISPR/Cas9 gene editing system].
    Cheng LH; Liu Y; Niu T
    Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):427-431. PubMed ID: 28565744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.